EVONETIX
evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniques we are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
EVONETIX
Industry:
Biopharma Biotechnology Life Science
Founded:
2015-01-01
Address:
Little Chesterford, Essex, United Kingdom
Country:
United Kingdom
Website Url:
http://www.evonetix.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
44.01 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Echo
Echo is a provider of an automated microscope intended for biological research and pathologies.
EnteroBiotix
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
PhagoMed
PhagoMed is a developer of a biotech platform designed to develop drugs and therapies.
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Providence Investment Company Limited
Providence Investment Company Limited investment in Series B - evonetix
Foresite Capital
Foresite Capital investment in Series B - evonetix
Cambridge Consultants
Cambridge Consultants investment in Series B - evonetix
DCVC
DCVC investment in Series B - evonetix
Molten Ventures
Molten Ventures investment in Series B - evonetix
Civilization Ventures
Civilization Ventures investment in Series B - evonetix
Rising Tide
Rising Tide investment in Series B - evonetix
Morningside Group
Morningside Group investment in Series B - evonetix
Innovate UK
Innovate UK investment in Grant - evonetix
Cambridge Consultants
Cambridge Consultants investment in Series A - evonetix
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-13 | Evonetix Appoints Colin McCracken as Chief Executive Officer |
Official Site Inspections
http://www.evonetix.com Semrush global rank: 2.74 M Semrush visits lastest month: 5.94 K
- Host name: kisscab2.miniserver.com
- IP address: 89.200.137.201
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
